Immunity & Metabolism of Diabetes

Welcome to the IMMEDIAB official website

IMMEDIAB: Innovation in diabetes research

IMMEDIAB stands for immunity and metabolism of diabetes. We work towards revealing therapeutic potential of immunometabolism in the world’s fastest growing disease, diabetes.

Learning centre

Education is the first step toward managing diabetes. 

Our learning centre is designed to help you understand diabetes and what you can do to get the best results from your care.

Working groups

Transcriptomics & Epigenomics

State-of-the-art studies in genetic susceptibility and epigenetic mechanisms of disease

Immunity

Immunometabolism at its finest, groundbreaking work bridging the gap between two fields

bioenergetics

Probing the mechanisms that fuel cellular function in health and disease

functional genomics

Cutting-edge analytical techniques bridging all working groups, driving towards precision therapy

Clinical science

Ensuring our work reaches the patient, bench-to-bedside has never looked better

PhD student working in the lab

Funders

European Research Council
Inserm
Société Francophone du Diabète
APHP
Fondation Francophone pour la Recherche sur le Diabète
European Foundation for the Study of Diabetes
Agence Nationale de la Recherche
Aviesan

Events and latest news

Collaborations

APHP
Université de Bourgogne logo
Karolinska institutet logo
University of Basel logo
Astrazeneca logo
University of Oxford logo